Holen Sie sich die Stockscreener-App
7.89
0.64%
0.05
Handel nachbörslich:
7.74
-0.15
-1.90%
Schlusskurs vom Vortag:
$7.84
Offen:
$7.85
24-Stunden-Volumen:
1.40M
Relative Volume:
0.57
Marktkapitalisierung:
$1.27B
Einnahmen:
$181.41M
Nettoeinkommen (Verlust:
$-59.56M
KGV:
-18.79
EPS:
-0.42
Netto-Cashflow:
$-38.83M
1W Leistung:
-0.13%
1M Leistung:
+41.91%
6M Leistung:
+110.40%
1J Leistung:
+198.86%
1-Tages-Spanne:
$7.7726
$7.97
1-Wochen-Bereich:
$7.66
$8.03
52-Wochen-Spanne:
$2.48
$8.03
Xeris Biopharma Holdings Inc Stock (XERS) Company Profile
Firmenname
Xeris Biopharma Holdings Inc
Sektor
Branche
Telefon
844-445-5704
Adresse
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Vergleichen Sie XERS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XERS
Xeris Biopharma Holdings Inc
|
7.89 | 1.28B | 181.41M | -59.56M | -38.83M | -0.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-11-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-03-28 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-28 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-21 | Eingeleitet | Jefferies | Buy |
| 2022-04-28 | Eingeleitet | Craig Hallum | Buy |
| 2021-11-17 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2020-02-18 | Eingeleitet | Piper Sandler | Overweight |
| 2018-07-16 | Eingeleitet | Jefferies | Buy |
| 2018-07-16 | Eingeleitet | Leerink Partners | Outperform |
| 2018-07-16 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Xeris Biopharma Holdings Inc Aktie (XERS) Neueste Nachrichten
Is Xeris Biopharma Holdings Inc. forming a breakout patternJuly 2025 Price Swings & AI Forecasted Entry and Exit Points - khodrobank.com
Technical analysis overview for Xeris Biopharma Holdings Inc. stock2025 Market Outlook & Reliable Breakout Forecasts - Newser
Technical signs of recovery in Xeris Biopharma Holdings Inc.Weekly Profit Summary & Fast Gain Stock Tips - Newser
Using data models to predict Xeris Biopharma Holdings Inc. stock movementPortfolio Risk Summary & Safe Capital Allocation Plans - Newser
Is Xeris Biopharma Holdings Inc. stock bottoming outPortfolio Update Report & Verified Technical Trade Signals - Newser
Bank Watch: Can Xeris Biopharma Holdings Inc. expand its profit marginsOil Prices & High Return Trade Guides - khodrobank.com
Xeris Pharmaceuticals stock hits 52-week high at 8.02 USD - Investing.com
Xeris Pharmaceuticals stock hits 52-week high at 8.02 USD By Investing.com - Investing.com Australia
Xeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 Revenue - MSN
What’s the fair value of Xeris Biopharma Holdings Inc. stockWall Street Watch & Risk Managed Investment Entry Signals - khodrobank.com
Candlestick signals on Xeris Biopharma Holdings Inc. stock todayBear Alert & Daily Price Action Insights - Newser
How cyclical is Xeris Biopharma Holdings Inc.’s revenue streamMarket Activity Report & Safe Entry Momentum Stock Tips - khodrobank.com
What’s the RSI of Xeris Biopharma Holdings Inc. stock2025 Valuation Update & Scalable Portfolio Growth Ideas - khodrobank.com
Is Xeris Biopharma Holdings Inc. stock a smart retirement pickWeekly Market Report & Low Drawdown Investment Ideas - khodrobank.com
Can Xeris Biopharma Holdings Inc. expand its profit marginsJuly 2025 Decliners & Verified Entry Point Detection - khodrobank.com
Investor Mood: Can Xeris Biopharma Holdings Inc. expand its profit margins2025 Major Catalysts & Low Drawdown Trading Techniques - khodrobank.com
What is Xeris Biopharma Holdings Inc.’s book value per shareTrade Entry Report & Low Risk High Win Rate Stock Picks - khodrobank.com
Is Xeris Biopharma Holdings Inc. stock a top performer YTD2025 Sector Review & Reliable Intraday Trade Plans - khodrobank.com
Will Xeris Biopharma Holdings Inc. see short term momentumGap Up & Daily Growth Stock Tips - Newser
Is Xeris Biopharma Holdings Inc. showing signs of accumulationChart Signals & Real-Time Chart Pattern Alerts - Newser
Xeris Biopharma Holdings Inc. stock volume spike explained2025 Momentum Check & Reliable Intraday Trade Plans - Newser
Is Xeris Biopharma Holdings Inc. stock ready for a breakout2025 Major Catalysts & Fast Exit and Entry Strategy Plans - Newser
Visualizing Xeris Biopharma Holdings Inc. stock with heatmaps2025 Fundamental Recap & Capital Protection Trade Alerts - Newser
Institutional scanner results for Xeris Biopharma Holdings Inc.July 2025 Breakouts & Free Reliable Trade Execution Plans - Newser
Is Xeris Biopharma Holdings Inc. forming bullish engulfing patternsWeekly Profit Report & Long-Term Capital Growth Strategies - 선데이타임즈
Will Xeris Biopharma Holdings Inc. Benefit From Sector Tailwinds getLinesFromResByArray error: size == 0 - thegnnews.com
How to build a dashboard for Xeris Biopharma Holdings Inc. stockBear Alert & Low Drawdown Momentum Ideas - Newser
Will Xeris Biopharma Holdings Inc. benefit from macro trendsWeekly Market Outlook & Daily Profit Focused Screening - Newser
Relative strength of Xeris Biopharma Holdings Inc. in sector analysisTrade Ideas & Safe Swing Trade Setup Alerts - Newser
Can a trend reversal in Xeris Biopharma Holdings Inc. lead to recoveryJuly 2025 Movers & High Conviction Trade Alerts - Newser
What MACD and RSI say about Xeris Biopharma Holdings Inc.July 2025 Action & Stepwise Trade Signal Implementation - Newser
How to recover losses in Xeris Biopharma Holdings Inc. stockRisk Management & Daily Risk Controlled Trade Plans - Newser
Finanzdaten der Xeris Biopharma Holdings Inc-Aktie (XERS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Xeris Biopharma Holdings Inc-Aktie (XERS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SHERMAN JEFFREY W | Director |
Aug 28 '25 |
Sale |
7.92 |
42,232 |
334,515 |
219,188 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):